These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34644703)

  • 1. S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens.
    Onorato A; Napolitano A; Spoto S; Incorvaia L; Russo A; Santini D; Tonini G; Vincenzi B
    Chemotherapy; 2021; 66(5-6):161-168. PubMed ID: 34644703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen.
    Vincenzi B; Daniele S; Frezza AM; Berti P; Vespasiani U; Picardi A; Tonini G
    Support Care Cancer; 2012 Jan; 20(1):135-9. PubMed ID: 21229271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen.
    Vincenzi B; Santini D; Frezza AM; Berti P; Vespasiani U; Picardi A; Tonini G
    Expert Opin Drug Saf; 2011 May; 10(3):345-9. PubMed ID: 21406026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.
    Santini D; Vincenzi B; Massacesi C; Picardi A; Gentilucci UV; Esposito V; Liuzzi G; La Cesa A; Rocci L; Marcucci F; Montesarchio V; Groeger AM; Bonsignori M; Tonini G
    Anticancer Res; 2003; 23(6D):5173-9. PubMed ID: 14981985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.
    Conroy T; Hebbar M; Bennouna J; Ducreux M; Ychou M; Llédo G; Adenis A; Faroux R; Rebischung C; Kockler L; Douillard JY
    Br J Cancer; 2010 Jan; 102(1):59-67. PubMed ID: 19920832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.
    Strickland G; Pauling J; Cavill C; McHugh N
    Clin Rheumatol; 2012 Aug; 31(8):1215-22. PubMed ID: 22588647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
    Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
    Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
    de Gramont A; Van Cutsem E; Schmoll HJ; Tabernero J; Clarke S; Moore MJ; Cunningham D; Cartwright TH; Hecht JR; Rivera F; Im SA; Bodoky G; Salazar R; Maindrault-Goebel F; Shacham-Shmueli E; Bajetta E; Makrutzki M; Shang A; André T; Hoff PM
    Lancet Oncol; 2012 Dec; 13(12):1225-33. PubMed ID: 23168362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric Properties of the Arabic Version of the Functional Assessment of Chronic Illnesses Therapy-Fatigue in Arabic Cancer Patients.
    Al Maqbali M; Hughes C; Gracey J; Rankin J; Hacker E; Dunwoody L
    J Pain Symptom Manage; 2020 Jan; 59(1):130-138.e2. PubMed ID: 31647976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue in intensive care survivors one year after discharge.
    Spadaro S; Capuzzo M; Valpiani G; Bertacchini S; Ragazzi R; Dalla Corte F; Terranova S; Marangoni E; Volta CA
    Health Qual Life Outcomes; 2016 Oct; 14(1):148. PubMed ID: 27756403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer related fatigue: A ubiquitous problem yet so under reported, under recognized and under treated.
    Kapoor A; Singhal MK; Bagri PK; Narayan S; Beniwal S; Kumar HS
    South Asian J Cancer; 2015; 4(1):21-3. PubMed ID: 25839015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Content Validity of Sjögren's Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren's.
    Griffiths N; Wratten S; Flynn J; Bookman AAM; Ndife B; Hueber W; Goswami P
    Rheumatol Ther; 2022 Dec; 9(6):1559-1574. PubMed ID: 36152275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial.
    Baguley BJ; Skinner TL; Jenkins DG; Wright ORL
    Clin Nutr; 2021 Jan; 40(1):245-254. PubMed ID: 32534948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue Subscale): Validity and Reliability of the Iranian Version.
    Meysami A; Yari H; Haghighat S; Montazeri A
    Oncol Res Treat; 2017; 40(12):789-793. PubMed ID: 29183033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
    Tinsley A; Macklin EA; Korzenik JR; Sands BE
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1328-36. PubMed ID: 21999576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) scale.
    Butt Z; Lai JS; Rao D; Heinemann AW; Bill A; Cella D
    J Psychosom Res; 2013 Jan; 74(1):64-8. PubMed ID: 23272990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
    Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial.
    Demmelmaier I; Brooke HL; Henriksson A; Mazzoni AS; Bjørke ACH; Igelström H; Ax AK; Sjövall K; Hellbom M; Pingel R; Lindman H; Johansson S; Velikova G; Raastad T; Buffart LM; Åsenlöf P; Aaronson NK; Glimelius B; Nygren P; Johansson B; Börjeson S; Berntsen S; Nordin K
    Scand J Med Sci Sports; 2021 May; 31(5):1144-1159. PubMed ID: 33527488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.
    Yennurajalingam S; Valero V; Lu Z; Liu DD; Busaidy NL; Reuben JM; Diaz Fleming C; Williams JL; Hess KR; Basen-Engquist K; Bruera E
    J Natl Compr Canc Netw; 2021 Dec; 20(3):235-243. PubMed ID: 34965510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.